echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Good news from several pharmaceutical companies: API products passed GMP on-site inspection

    Good news from several pharmaceutical companies: API products passed GMP on-site inspection

    • Last Update: 2020-02-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] the industry believes that GMP will continue to play the role of "business card" for market expansion for quite a period in the future Through GMP on-site inspection of pharmaceutical products, it means that the production line meets GMP requirements, which helps to enhance the industry's influence and competitiveness, and at the same time, it allows enterprises to continue to maintain stable product quality, improve production capacity, meet market demand, etc Recently, many pharmaceutical companies have heard good news that their API products have passed GMP on-site inspection Tonghe Pharmaceutical Co., Ltd.: the API celecoxib passed the on-site inspection of PMDA in Japan On the evening of February 18, Tonghe Pharmaceutical Co., Ltd announced that recently, the API celecoxib of the company passed the GMP on-site inspection of PMDA in Japan The data showed that celecoxib was mainly used to relieve the symptoms and signs of osteoarthritis and adult rheumatoid arthritis The company said that the company passed the Japanese PMDA on-site inspection, creating conditions for the successful entry of celecoxib API into the Japanese market Northeast Pharmaceutical: Several API products have passed the on-site inspection Northeast Pharmaceutical recently announced that the company's API vitamin C has passed the on-site inspection Northeast Pharmaceutical said that the GMP on-site inspection marks that the company's new vitamin C production line has obtained legal production qualification and meets the conditions for marketing, which is conducive to improving the production capacity of the company's high-quality API and providing products that meet the quality standards continuously and stably In addition, in the evening of February 10, it was announced that piracetam, levocarnitine and amantadine salt, the company's API, had passed the on-site inspection Northeast Pharmaceutical said it will continue to maintain a stable production management and quality assurance system to better meet market demand and promote sustainable development of the company Erkang pharmaceutical: 8 kinds of APIs passed the GMP on-site inspection In early February, Erkang pharmaceutical announced that its wholly-owned subsidiary Hunan xiangyikang Pharmaceutical Co., Ltd xiangyikang's 8 APIs, including paracetamol, niacin, cinnarizine, chloramphenicol, tripitol, cyclophosphamide, furazolidone, and furacilin, met the requirements of the pharmaceutical production quality management specification and passed the GMP on-site inspection Zoelli Pharmaceutical Co., Ltd.: the raw material medicine Wuling mushroom powder passed the GMP on-site inspection On February 18, zoelli Pharmaceutical Co., Ltd issued a notice that the company's raw material medicine Wuling mushroom powder passed the GMP on-site inspection According to the announcement, the new production line of zoelli Pharmaceutical Co., Ltd.'s investment project of raising funds through non-public issuance of shares "construction project of production line with an annual output of 400 tons of Wuling mushroom powder" passed the GMP on-site inspection The data show that Wuling powder is a kind of modern Chinese herbal medicine which is made by biological fermentation technology and is isolated from the medicinal fungus Wuling ginseng According to the data of minenet, only Wuling powder of zoli pharmaceutical has been approved for listing It is reported that soli pharmaceutical develops a series of product strategies around Wuling powder Wuling capsule, which is made of Wuling powder, is one of the main varieties of soli pharmaceutical According to zoelli pharmaceutical's report for the first half of 2019, the operating revenue of zoelli pharmaceutical in the first half of 2019 is 428 million yuan, of which the operating revenue of Wuling series products is 225 million yuan, accounting for more than 50% of the total operating revenue Zoelli pharmaceutical said that the production line passed the GMP on-site inspection, which is conducive to improving the production capacity and efficiency of Wuling powder API  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.